Abiopharma

🔍 Sena Peter P III (Executive)

Company: SOUTHERN CO (SO)

Report Date: 2026-06-28

Detailed Transactions and Holdings:

• Acquired 712 shares of Southern Company Common Stock (Direct)
  Date: 2026-06-28 | Code: M | equity_swap_involved: false | shares_owned_after: 31,517.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 316 shares of Southern Company Common Stock at $97.16 per share (Direct)
  Date: 2026-06-28 | Code: F | equity_swap_involved: false | shares_owned_after: 31,201.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 667 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-06-28 | Code: M | equity_swap_involved: false | shares_owned_after: 667.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3

Footnotes:

• F1: Shares acquired upon vesting of second 1/3 of performance restricted stock units granted on June 28, 2024. Includes 45 accrued dividend equivalent units.
• F2: Shares withheld to satisfy required state and federal tax withholding requirements.
• F3: Represents second 1/3 of performance restricted stock units granted on June 28, 2024. The remaining award will vest in 2027. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Additional units will be acquired with deemed dividends. Shares will be withheld upon vesting to satisfy tax requirements.